ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZurichAmicus Therapeutics Switzerland GmbH
Amicus Therapeutics Switzerland GmbH Logo
Verified· 2 sources

Amicus Therapeutics Switzerland GmbH

Summary

About the company

The core activity of Amicus Therapeutics is the development of innovative therapies for the treatment of rare genetic diseases, particularly lysosomal storage disorders such as Fabry disease and Pompe disease. The company focuses on developing "First-in-Class" treatments that represent new classes of active ingredients to treat these diseases.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Pharmaceutical Industry
✓ Offered1
Medicines for lysosomal storage diseases
Medicines for Fabry disease and Pompe disease in the area of lysosomal storage diseases; information on the corresponding therapeutic areas and on the product Galafold® (Migalastat).
Comparisons

Amicus Therapeutics Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Amicus Therapeutics Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Amicus Therapeutics Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Dufourstrasse 49
8008 Zurich

At a glance

Legal form
Limited Liability Company
UID
CHE-435.854.542
Founded
2019 · 7 years
Last commercial register change
September 24, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once Amicus Therapeutics Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

DA
Dr. Andres Pharma AG
Zurich
SS
SSCB SWISS STEM CELLS BIOTECH AG
Zurich
DF
Dr. Falk Pharma AG
Glattbrugg
RI
Repertoire Immune Medicines (Switzerland) AG
Schlieren
RE
Redux Energy GmbH
Zurich
OP
Otsuka Pharmaceutical (Switzerland) GmbH
Glattbrugg
BA
BTRY AG
Dübendorf
CG
Conmetec GmbH
Hagenbuch Zh